Nektar Therapeutics
NKTR
#6443
Rank
NZ$1.30 B
Marketcap
NZ$64.38
Share price
3.40%
Change (1 day)
195.11%
Change (1 year)

Nektar Therapeutics (NKTR) - P/B ratio

P/B ratio as of February 2026 : 9.18

According to Nektar Therapeutics 's latest financial reports the company has a price-to-book ratio of 12.4747.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Nektar Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-3110.4260.09%
2024-12-312.88250.32%
2023-12-310.8229-28.98%
2022-12-311.16-68.43%
2021-12-313.6729.62%
2020-12-312.834.43%
2019-12-312.71-18.37%
2018-12-313.32-96.9%
2017-12-31107403.16%
2016-12-3121.3-94%
2015-12-31355533.42%
2014-12-3156.0-480.63%
2013-12-31-14.7-180.96%
2012-12-3118.2461.25%
2011-12-313.24-75.84%
2010-12-3113.457.74%
2009-12-318.49214.19%
2008-12-312.70-6.41%
2007-12-312.89-52.77%
2006-12-316.1138.42%
2005-12-314.4220.6%
2004-12-313.66-21.37%
2003-12-314.66114.58%
2002-12-312.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
6.97-24.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.62-82.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
19.2 109.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.42-84.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.41-41.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
12.7 38.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
1.12-87.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
3.34-63.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland